← Eichor
Study identifier: NCT07250672 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Patient-Specific 3D Action Observation Training in Parkinson's Disease

Condition: Parkinson Disease · Virtual Reality · Action Obervation Training  ·  Sponsor: Abant Izzet Baysal University

PhaseNA
Planned participants24
Who can joinAll sexes, 50 Years to 85 Years
Healthy volunteersNo

About this study

Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals. The aim of the present study is to examine the effects of action observation training, delivered in a fully immersive virtual reality environment using each patient's own 3D motion recordings, on bradykinesia and other disease-related parameters.

This description comes directly from the study's public registry record.

Talk to the study team

Enes T Benli, Ph.D  ·  +905387359268  ·  enestayyipbenli@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Abant Izzet Baysal University Faculty of Health ScienceBolu, Bolu, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07250672